About 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one
4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one (PubChem CID 71203058) has the molecular formula C21H17F3N4O
and a molecular weight of 398.39 g/mol. Its IUPAC name is 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one.
Molecular Properties
| Compound Name | 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one |
| PubChem CID | 71203058 |
| Molecular Formula | C21H17F3N4O |
| Molecular Weight | 398.39 g/mol |
| Exact Mass | 398.14 |
| IUPAC Name | 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one |
| SMILES | O=C1c2cc(-c3ccc(C(F)(F)F)cc3)ccc2NCCN1Cc1ncccn1 |
| InChI | InChI=1S/C21H17F3N4O/c22-21(23,24)16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(29)28(11-10-25-18)13-19-26-8-1-9-27-19/h1-9,12,25H,10-11,13H2 |
| InChIKey | XJLLRWNKTWAQQN-UHFFFAOYSA-N |
| XLogP | 4.23 |
| TPSA | 58.12 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 398.39 |
| LogP ≤ 5 | 4.23 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Analyze 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one?
The IUPAC name of 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one (CID 71203058) is 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one.
What is the SMILES notation for 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one?
The canonical SMILES for 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one is O=C1c2cc(-c3ccc(C(F)(F)F)cc3)ccc2NCCN1Cc1ncccn1.
What is the InChIKey of 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one?
The InChIKey is XJLLRWNKTWAQQN-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H17F3N4O/c22-21(23,24)16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(29)28(11-10-25-18)13-19-26-8-1-9-27-19/h1-9,12,25H,10-11,13H2.
What are the key properties of 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one?
4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one has a molecular weight of 398.39 g/mol, XLogP of 4.23, 3 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-1,4-benzodiazepin-5-one is sourced from PubChem (CID 71203058), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).